iNtRON Biotech to issue Convertible Bonds
인트론바이오
048530
Signal Score
Historical Avg Return (5d)
+0.26%
Data Coverage
100%n=2418
Risk-adjusted indicator based on 2418 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Call Option: Up to 30% of initial registered amount per underwriter
- • Call Option Exercise Period: July 15, 2027 - July 15, 2028
- • Early Redemption Period: July 15, 2027 - April 15, 2029
AI Analysis Summary
iNtRON Biotechnology has decided to issue convertible bonds. The report details the terms, including early redemption options for bondholders from July 15, 2027, to April 15, 2029, and a call option for the company or a third party to repurchase up to 30% of the bonds per underwriter from July 15, 2027, to July 15, 2028. Specific financial figures for the total bond amount, conversion price, and number of shares were not provided in the content, limiting a precise dilution impact assessment. The purpose of the funds and the exact dilution rate are currently undisclosed, leading to a neutral financial impact assessment.
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.